BioCentury
ARTICLE | Clinical News

RSV-F vaccine: Phase II data

April 8, 2013 7:00 AM UTC

Top-line data from a double-blind, placebo-controlled, U.S. Phase II trial in 330 women of child-bearing age showed that 60 and 90 µg doses of intramuscular RSV-F vaccine on days 0 and 28 with and wit...